Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Yoshiaki Okumura"'
Autor:
Shunya Nakane, Akihiro Mukaino, Yoshiaki Okumura, Hiroaki Hirosawa, Osamu Higuchi, Hidenori Matsuo, Mosaburo Kainuma, Yuji Nakatsuji
Publikováno v:
Journal of Personalized Medicine, Vol 14, Iss 5, p 485 (2024)
Background: Functional gastrointestinal disorders (FGIDs), including functional dyspepsia (FD) and irritable bowel syndrome (IBS), are characterized by chronic and recurrent gastrointestinal symptoms. Clinically, FD and IBS often resemble gastrointes
Externí odkaz:
https://doaj.org/article/97597c21edb148f0b59db0ee97685f70
Autor:
Yoshiaki Okumura
Publikováno v:
Functiones et Approximatio Commentarii Mathematici. 65
For an extension $K/\mathbb{F}_q(T)$ of the rational function field over a finite field, we introduce the notion of virtually $K$-rational Drinfeld modules as a function field analogue of $\mathbb{Q}$-curves. Our goal in this article is to prove that
Autor:
Yoshiaki Okumura
Publikováno v:
Kyushu Journal of Mathematics. 73:295-316
In the arithmetic of function fields, Drinfeld modules play the role that elliptic curves play in the arithmetic of number fields. The aim of this paper is to study a non-existence problem of Drinfeld modules with constrains on torsion points at plac
Autor:
Satoshi Maekawa, Fumihiko Hatao, Kazunori Kasama, Hidetoshi Kiyonaga, Tetsuya Kakuma, Seigo Kitano, Masayuki Ohta, Yukio Sawada, Yasuyuki Seto, Takayuki Masaki, Michio Kaminishi, Yoshiaki Okumura, Hiroki Imazu, Yuko Kitagawa, Masahiko Inamori, Masafumi Inomata
Publikováno v:
Asian journal of endoscopic surgeryREFERENCES. 14(3)
Introduction Endoscopic intragastric balloon (IGB) placement has been performed in Japan since 2004. The nationwide surveys were repeatedly carried out to confirm the effectiveness and safety of IGB in Japan. We herein present the accumulated results
Autor:
YOSHIAKI OKUMURA
Publikováno v:
Functiones et Approximatio Commentarii Mathematici; Dec2021, Vol. 65 Issue 2, p157-174, 18p
Autor:
Rie Osaki, Akira Andoh, Ayumi Asada, Makoto Shioya, Takayuki Takeuchi, Takashi Nishimura, Yoshiaki Okumura
Publikováno v:
Biomedical Reports. 3:247-253
The outcome of antiviral therapy is associated with viral and host factors. In the present study, the association between MHC class I-related chain B (MICB) genotypes and therapeutic response to pegylated interferon plus ribavirin (PEG-IFN/RBV) thera
Autor:
Tetsuya Inoue, Kazuo Yamamoto, Masako Fukuda, Keiko Takahashi, Shigemi Nakajima, Yoshihide Fujiyama, Yoshiaki Okumura, Jin Sato
Publikováno v:
Journal of Gastroenterology and Hepatology. 25:S138-S143
Background and Aims: The aim of this study was to establish the spectra of functional gastrointestinal disorders (FGID) in a Japanese outpatient office in Rome III. Methods: The Rome III Diagnostic Questionnaire for Adult Functional GI Disorders was
Autor:
Hisayuki Inoue, Yoshiaki Okumura, Tadao Bamba, Utako Yoshioka, Junya Tamba, Yoshihide Fujiyama, Yutaka Shintani
Publikováno v:
Pancreas. 16:205-210
A 38-year-old male patient who had been treated for Crohn's disease was found to have serum lipase activity that was persistently increased approximately 10-fold above the normal upper limit. He was diagnosed with chronic pancreatitis based on slight
Autor:
Yoshiaki Okumura, Yoshihide Fujiyama, Akira Andoh, Makoto Shioya, Hirotsugu Imaeda, Takayuki Takeuchi, Rie Osaki, Tomoki Aomatsu, Takashi Nishimura
Publikováno v:
Molecular Medicine Reports.
Ribavirin (RBV)-induced anemia is a serious side effect of pegylated interferon (PEG-IFN) plus RBV therapy which is the standard care most effective for hepatitis C virus (HCV) infection. In the present study, we investigated the association of inosi
Autor:
Takayuki Takeuchi, Shigeki Bamba, Yoshiaki Okumura, Yoshihide Fujiyama, Makoto Shioya, Tamio Nakahara, Takashi Nishimura, Shinobu Nakajo, Akira Andoh, Rie Osaki
Publikováno v:
Molecular Medicine Reports.
We recently reported that the interleukin (IL)-28B major genotype is a predictor of early suppression of the hepatitis C virus (HCV) at 12 weeks in response to pegylated interferon (PEG-IFN) plus ribavirin (RBV) therapy. The present study investigate